| For: | Xu G, Tian KL, Liu GP, Zhong XJ, Tang SL, Sun YP. Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis. World J Gastroenterol 2002; 8(3): 575-576 [PMID: 12046096 DOI: 10.3748/wjg.v8.i3.575] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i3/575.htm |
| Number | Citing Articles |
| 1 |
Paulina Nuñez, Sandra García Mateo, Rodrigo Quera, Fernando Gomollón. La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular. Gastroenterología y Hepatología 2021; 44(3) doi: 10.1016/j.gastrohep.2020.09.002
|
| 2 |
Wei-Guo Dong, Shao-Ping Liu, Hai-Hang Zhu, He-Sheng Luo, Jie-Ping Yu. Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis. World Journal of Gastroenterology 2004; 10(4): 606-609 doi: 10.3748/wjg.v10.i4.606
|
| 3 |
Gang Xu, Ya-Li Zhang, Wen Huang. Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients. World Journal of Gastroenterology 2004; 10(6): 922-923 doi: 10.3748/wjg.v10.i6.922
|
| 4 |
Petros Zezos, Georgia Papaioannou, Nikolaos Nikolaidis, Themistoclis Vasiliadis, Olga Giouleme, Nikolaos Evgenidis. Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation. World Journal of Gastroenterology 2005; 11(48): 7639-7645 doi: 10.3748/wjg.v11.i48.7639
|
| 5 |
Matthew G. Nevulis, Colby Baker, Edward Lebovics, William H. Frishman. Overview of Link Between Inflammatory Bowel Disease and Cardiovascular Disease. Cardiology in Review 2018; 26(6) doi: 10.1097/CRD.0000000000000214
|
| 6 |
Józef Drzewoski, Anita Gąsiorowska, Ewa Małecka‐Panas, Edward Bald, Leszek Czupryniak. Plasma total homocysteine in the active stage of ulcerative colitis. Journal of Gastroenterology and Hepatology 2006; 21(4) doi: 10.1111/j.1440-1746.2006.04255.x
|
| 7 |
B B Lee. Venous malformation and haemangioma: differential diagnosis, diagnosis, natural history and consequences. Phlebology: The Journal of Venous Disease 2013; 28(1_suppl) doi: 10.1177/0268355513475960
|
| 8 |
Valeriy N. Marchenko, Oksana B. Shchukina, Denis A. Davydov, Anastasiya I. Bogacheva, Veniamin V. Banko, Alexandra R. Makarenko. Endothelial dysfunction in axial spondyloarthritis associated with inflammatory bowel disease. HERALD of North-Western State Medical University named after I.I. Mechnikov 2023; 14(4) doi: 10.17816/mechnikov108408
|
| 9 |
Yusuf Üstün, Serta Kilincalp, Şahin Çoban, Yusuf Coşkun, İlhami Yüksel, Aydan Ongun, İrfan Soykan, Mehmet Bektaş, Murat Törüner, Hülya Çetinkaya, Necati Örmeci. Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease. Medical Science Monitor 2016; 22 doi: 10.12659/MSM.898160
|
| 10 |
Paulina Nuñez, Sandra García Mateo, Rodrigo Quera, Fernando Gomollón. Inflammatory bowel disease and the risk of cardiovascular diseases. Gastroenterología y Hepatología (English Edition) 2021; 44(3) doi: 10.1016/j.gastre.2021.02.003
|
| 11 |
Wan Feng, Lei Zhu, Song Zhao, Kai Zheng, Luzhou Xu, Hong Shen. Fibrinogen, FDP and D-Dimer as Potential Biomarkers for Disease Severity in Ulcerative Colitis: A Retrospective Study. International Journal of General Medicine 2024; doi: 10.2147/IJGM.S477285
|